PRESS RELEASE Wollongong locals to participate in Australia’s largest primary prevention Aspirin Trial Wollongong, October 3, 2013 – The ASPREE (ASPirin in Reducing Events in the Elderly) study – the largest primary prevention aspirin study ever undertaken in older people – is calling on local residents from Wollongong and surrounding regions to participate in the study.…Details
ASPREE has now enrolled over 12,500 participants in Australia, our original target when the trial was launched in 2010. To our wonderful older members of the community participating in ASPREE and to their supportive family and friends and GPs, thank you. Congratulations also to our hardworking team.
Sapphire Coast GP, Dr Mackinnon featured in an article “An aspirin a day for the elderly” in the Bega District News. Dr Mackinnon, one of over 2000 registered co-investigators to ASPREE, the largest clinical trial ever conducted in general practice in Australia, explained why he is involved in this study. Read the full Bega District News…Details
The ASPREE Healthy Ageing Biobank team marks the 8,000th participant to volunteer for the study with a delightful cake made by one of their talented research assistants.
A leading Australian medical researcher recommends that healthy people of all ages should consult their GP prior to commencing aspirin for disease prevention. Professor Mark Nelson (pictured left) was commenting after new research suggested that aspirin may reduce the risk of women developing colon cancer. He said the study, which found that women who took…Details
The ASPREE (ASPirin in Reducing Events in the Elderly) study hosted a study update and morning tea at the Altona Senior Citizens Centre to celebrate reaching over 200 participants in the Melbourne’s western suburbs. Special guest Hobson’s Bay City Councillor Sandra Wilson- joined 100 local study participants and guests, and research staff at the celebration. Associate…Details
Mildura Mayor Glenn Milne and Councillor Sharyon Peart formally launched the ASPREE (ASPirin in Reducing Events in the Elderly) study in the regional city recently. Over 50 ASPREE participants, their family, friends, GPs, practice managers and other interested parties attended the event at the Monash Regional Clinical School in Mildura. ASPREE Executive Officer, Associate Professor Robyn…Details
Medical Oncologist Dr Andrew Haydon, who oversees cancer aspects of a world-first aspirin trial, ASPREE, said that the recent association between aspirin and a reduced risk of developing melanoma was a call for closer investigation of aspirin’s anti-tumour effect. Melanoma is the most deadly form of skin cancer and is on the rise in Australia.…Details
The ASPREE (ASPirin in Reducing Events in the Elderly) study hosted a study update and morning tea at the Windsor Community Precinct on Friday 8th March to celebrate reaching 400 participants in the Launceston region. Special guest and Tamar Valley resident Peter Cundall – renowned horticulturalist and former host of the ABC program Gardening Australia –…Details
World-first Aspirin study reaches new milestone – 10,000 participants PRESS RELEASE: Melbourne, February 21 2013 – The largest primary prevention aspirin study ever undertaken in older people has reached an important milestone, signing up 10,000 participants in Australia. The landmark ASPREE (ASPirin in Reducing Events in the Elderly) study is investigating whether a daily low…Details